<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01112891</url>
  </required_header>
  <id_info>
    <org_study_id>H09-01261</org_study_id>
    <secondary_id>F08-03892</secondary_id>
    <nct_id>NCT01112891</nct_id>
  </id_info>
  <brief_title>Vitamin D in Pregnancy and Lactation</brief_title>
  <official_title>Vitamin D Dose-response Study Throughout Pregnancy and Lactation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Vitamin D is vital throughout pregnancy and lactation for both maternal and
      infant health. Health Canada recommends women take the AI of 5ug/day of vitamin D during
      pregnancy, however, it is unknown how much vitamin D is necessary to ensure both mother and
      baby reach a vitamin D serum concentration of 25OHD&gt;75nmol/L.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose &amp; Hypothesis: This project aims to determine maternal and infant responses vitamin D
      supplementation in pregnancy and lactation. It is hypothesized that the current AI of 5 μg of
      vitamin D will be inadequate for women and their infants in Canada to achieve optimal 25OHD
      concentrations (&gt; 75nmol/L).

      Methods: Healthy pregnant women between 18-42 years of age without history of pregnancy
      complications will be recruited for a double-blind, randomized, controlled trial where they
      will receive one of three different dosages of vitamin D (10, 25 and 50ug/day) as part of a
      standard prenatal vitamin. The study at 18 plus/minus 3 weeks gestation and will carry on
      throughout pregnancy and lactation. Mother and infant vitamin D levels in breast milk and
      blood will be measured at regular intervals. Skin colour will be measured via light
      reflectometry. Bone biomarkers such as plasma osteocalcin and urinary n-telopeptide will be
      assessed. Dietary vitamin D intake and sun exposure will be estimated using a food frequency
      and lifestyle questionnaire. Data will be analyzed using multiple regression analysis
      controlling for baseline values.

      Expected Results &amp; Conclusions: It is expected that greater vitamin D intakes (25, 50ug/day)
      will be necessary to raise maternal and infant serum concentrations to 25OHD&gt;75nmol/L to
      avoid infant supplementation. This data will aid policy makers, mothers and healthcare
      workers in recommended and appropriate vitamin D dosage throughout pregnancy and lactation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>25(OH)D Plasma Concentrations</measure>
    <time_frame>18 weeks gestation for mother</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>25(OH)D Plasma Concentrations</measure>
    <time_frame>28 weeks gestation for mother</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>25(OH)D Plasma Concentrations</measure>
    <time_frame>36 weeks gestation for mother</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>25(OH)D Plasma Concentrations</measure>
    <time_frame>16 weeks post-partum for mother &amp; infant</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">225</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>10 ug/day Vitamin D as part of standard pre-natal vitamin supplement, taken from 18 weeks gestation to 6 months postpartum.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>25 ug/day Vitamin D as part of standard pre-natal vitamin supplement, taken from 18 weeks gestation to 6 months postpartum.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>50 ug/day Vitamin D as part of standard pre-natal vitamin supplement, taken from 18 weeks gestation to 6 months postpartum.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women between 18-42 years of age

          -  within 18 plus/minus 3 weeks gestation

          -  planning to breastfeed their infant

          -  a singleton pregnancy

        Exclusion Criteria:

          -  Any co-morbid condition such pre-gestational diabetes, TB, cardiac or renal disease,
             HIV/AIDS, chronic hypertension, inflammatory bowel disease, autoimmune disease, liver
             disease, or epilepsy; conditions associated with vitamin D malabsorption: celiac
             disease, gastric bypass;

          -  History of previous adverse pregnancy outcome [preterm delivery &lt;37; weeks GA,
             stillbirth, severe pre-eclampsia, eclampsia, HELLP syndrome (hemolytic anemia,
             elevated liver enzymes, and low platelet count)];

          -  Women will also be ineligible if they are taking more than 10 µg day supplemental
             vitamin D or drugs known to interfere with vitamin D metabolism (i.e corticosteroids).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tim Green, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sheila M. Innis, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael R. Lyon, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonia W. Shand, Dr</last_name>
    <role>Study Director</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter von Dadelszen, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Russ Freisen, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kaitlin March</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tina Li</last_name>
    <role>Study Chair</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2010</study_first_submitted>
  <study_first_submitted_qc>April 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2010</study_first_posted>
  <last_update_submitted>December 12, 2014</last_update_submitted>
  <last_update_submitted_qc>December 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Infant</keyword>
  <keyword>Lactation</keyword>
  <keyword>Dose-Response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

